Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Analytical validation of therapeutic drug monitoring (TDM) on AxSYM Abbott analyzer (CROSBI ID 164663)

Prilog u časopisu | stručni rad

Nikolac, Nora ; Šimundić, Ana-Maria ; Vukelić, Nada ; Papić Futač, Dalja ; Vrkić, Nada Analytical validation of therapeutic drug monitoring (TDM) on AxSYM Abbott analyzer // Biochemia medica, 20 (2010), 2; 253-259. doi: 10.11613/BM.2010.032

Podaci o odgovornosti

Nikolac, Nora ; Šimundić, Ana-Maria ; Vukelić, Nada ; Papić Futač, Dalja ; Vrkić, Nada

engleski

Analytical validation of therapeutic drug monitoring (TDM) on AxSYM Abbott analyzer

Careful monitoring of drug concentration (therapeutic drug monitoring, TDM) is essential for a large number of drugs. The aim of this study was to evaluate analytical performance of Abbott AxSYM analyzer for therapeutic drug monitoring of theophylline, carbamazepine, phenobarbital and valproic acid. For the purpose of analytical validation following parameters were determined for all analytes: inaccuracy (bias), within-run and between-run imprecision and measurement uncertainty. Additionally, concentration of valproic acid was compared with the previously used analytical system (TDx FLx Abbott analyzer) for 30 patients’ samples. Inaccuracy results (bias) were as follows: for theophylline from –3.66% to –5.84% ; for carbamazepine –0.46% to 1.00% ; for phenobarbital –1.83% to –8.08% and for valproic acid from – 1.01% to –5.65%. The highest coefficient of variation (CV) for within run imprecision was observed for phenobarbital (7.07%) and the lowest for theophylline (2.71%). The highest CV for between run imprecision was observed for carbamazepine (4.73%) and the lowest for theophylline (2.94%). The highest measurement uncertainty was observed for phenobarbital assay (21.7%) and the lowest for carbamazepine (10.7%). Passing-Bablock regression analysis of valproic acid comparison on two analyzers showed statistically significant, but clinically insignificant deviation in slope of the regression equation (b = 1.121 ; 95% CI = 1.028– 1.197) ; however the Cusum linearity test proved that there was a linear relationship between two methods. In conclusion, analytical validation fulfilled all previously established criteria and could be implemented in a routine laboratory work.

analytical validation; measurement uncertainty; valproic acid; phenobarbital; carbamazepine; theophylline

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

20 (2)

2010.

253-259

objavljeno

1330-0962

10.11613/BM.2010.032

Povezanost rada

Kliničke medicinske znanosti, Farmacija

Poveznice
Indeksiranost